tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nissha to Acquire Vietnam’s USM Healthcare, Expanding Medical Device Footprint in Southeast Asia

Story Highlights
  • Nissha will acquire 60% of Vietnam-based USM Healthcare, making it a key medical-device subsidiary to support growth in Southeast Asia.
  • The deal gives Nissha a competitive stent and orthopedic device platform, boosting its global CDMO strategy and accelerating expansion in Asian markets.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nissha to Acquire Vietnam’s USM Healthcare, Expanding Medical Device Footprint in Southeast Asia

Claim 50% Off TipRanks Premium

Nissha Co.Ltd. ( (JP:7915) ) has provided an announcement.

Nissha Co., Ltd. has decided to acquire 60% of the shares of USM Healthcare Medical Devices Factory Joint Stock Company, a Ho Chi Minh City–based manufacturer of cardiology stents and orthopedic devices, thereby making it a subsidiary and specified subsidiary given the relative size of its capital. With USM Healthcare’s vertically integrated model from design and development through regulatory approval, manufacturing and sales, and its status as Vietnam’s only domestic stent producer benefiting from supportive local policies, Nissha gains a competitive and growing production base in Southeast Asia’s rapidly expanding medical devices market. Nissha and its local unit Nissha Vietnam Co., Ltd. will hold 59.99% and 0.01% of USM Healthcare respectively, and plan to combine Nissha’s global CDMO know-how, quality management, and customer networks in the US and Japan with USM Healthcare’s capabilities to strengthen and streamline existing operations while accelerating geographic expansion of medical device CDMO services across Southeast Asia.

The most recent analyst rating on (JP:7915) stock is a Hold with a Yen1395.00 price target. To see the full list of analyst forecasts on Nissha Co.Ltd. stock, see the JP:7915 Stock Forecast page.

More about Nissha Co.Ltd.

Nissha Co., Ltd. is a Japan-based diversified manufacturer listed on the Tokyo Stock Exchange Prime Market that is increasingly focusing on the global medical sector, including medical devices, pharmaceuticals, and healthcare products. Leveraging advanced design, development and manufacturing capabilities—particularly in minimally invasive surgical instruments and contract design/development and manufacturing (CDMO) services—the group aims to raise the medical segment’s share of consolidated net sales to 50% by 2030, with a strategic market focus on the United States and the broader Asia region.

Average Trading Volume: 289,303

Technical Sentiment Signal: Sell

Current Market Cap: Yen60.95B

Learn more about 7915 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1